.jpg)
Search
- 6 hours ago
- 3 min
Compounding pharmacy suppporting telemedicine, Curexa Pharmacy, receives investment
Curexa’s broad range of services include pre-launch support, customized formulations, API integration, and packaging/branding
- 2 days ago
- 1 min
Startup Avivomed closes on $32 million for neuromodulation technology platforms
Avivomed is developing and commercializing next generation neuromodulaton technology to treat patients suffering from chronic diseases.
- 4 days ago
- 2 min
MANA Therapeutics closes on $42 million for nonengineered, off-the-shelf, allogeneic cell therapies
MANA Therapeutics is harnessing the natural immune system to develop broadly accessible, ready-to-use cellular therapies to improve outcomes
- Nov 28
- 2 min
Enzychem and Zydus Cadila partner to manufacture COVID plasmid DNA vaccine in Korea
yCoV-D® was recently granted emergency use approval (EUA) by India’s national regulatory agency for subjects 12 years and above.
- Nov 26
- 3 min
Leading AI medical provider, Lunit, closes on pre-IPO round of $61 million
Lunit develops AI-powered diagnostic tools for cancer screening, and biomarkers that can predict patients who respond to specific therapies.
- Nov 25
- 3 min
Lixte Biotechnology (Nasdaq: LIXT) resumes enrollment for its trial for recurrent, malignant tumors
THE study is designed to determine the extent to which LB-100 enters recurrent GBMs and related brain tumors.
- Nov 24
- 2 min
Evoq Technologies launches smartphone-based product for retinal testing
Evoq is focused on technology available to doctors and scientists to enable them to discover and develop new treatments for blindness.
- Nov 22
- 3 min
Healint and Nestle Health Science Partners initate a virtual study on ketogenic migraine treatment
Migraine is the sixth most disabling illness in the world, which affects around a billion people worldwide.
- Nov 19
- 3 min
Alpheus Medical raises $16 million for human trials of therapy for solid body cancers
The company's lead product utilizes a novel, non-invasive drug-device combination for outpatient treatment of rGBM.
- Nov 17
- 2 min
Amcyte Pharma launches nasal spray to reduce COVID transmission
We are excited to be commercializing Nasitrol nasal spray, a product that has shown such promise as a prophylaxis against COVID transmission
- Nov 16
- 2 min
Bayshore Pharmaceuticals announces three new approved generic drugs
Bayshore uses its extensive knowledge and experience in global API and Finished Dosage Form manufacturing to differentiate itself.
- Nov 15
- 3 min
ScaleReady launches improved Wilson Wolf G-Rex product for cell and gene therapy
As cell and gene therapies have great lifesaving potential, the need for reliable and automatable closed system cell expansion is important
- Nov 12
- 3 min
HealthSnap raises fresh capital of $5 million to scale remote patient monitoring platform
HealthSnap helps healthcare providers manage chronic conditions such as hypertension, diabetes, and heart failure.
- Nov 10
- 2 min
NovaBay Pharmaceuticals (NYSE: NBY) closes on acquisition of DERMAdoctor
NovaBay Pharmaceuticals develops and sells scientifically created and clinically proven consumer products for the eyecsre and skincre market
- Nov 9
- 2 min
PDS Biotechnology licenses from National Cancer Institute proteins for the treatment of cancers
PDS Biotech is a clinical-stage immunotherapy company developing a growing pipeline of cancer immunotherapies.
- Nov 8
- 2 min
Press Ganey partners with Doximity for patient-feedback following telehealth visits
More than 63 million virtual visits were conducted on Doximity’s platform in the fiscal year ending March 31, 2021.
- Nov 6
- 3 min
Preclinical Parthenon Therapeutics closes on $65 million to advance anti-cancer therapeutics
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
- Nov 4
- 3 min
Infusion for Health wraps up $50 million for expansion of its chronic disease management platform
In the past year, Infusion for Health has more than quadrupled the size of its business and geographic reach to more than 20 million lives.
- Nov 3
- 2 min
Argon Medical launches unique portal vein access sets intended for transjugular liver access
The new devices addresse the common challenges physicians encounter when placing a Transjugular Intrahepatic Portosystemic Shunt (TIPS).
- Nov 2
- 2 min
BioSig (NASDAQ: BSGM) Increases Case Volume Estimates of its signal processing for arrhythmia care
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform.